Skip directly to site content
Are You Still There?
Due to inactivity, you will be signed out in two minutes unless you click 'Continue'.

Panel: 
AR Bank #

Biosample Accession #:

   


Panel:    |  Enterobacterales Carbapenem Breakpoint (BIT)  |  Piperacillin-tazobactam +aminoglycosides for Enterobacterales (PTA) (Custom)  |  PTA - BIT set only (Custom)


MIC (μg/ml) Results and Interpretation
Drug MIC (μg/ml) INT
S – I –R Interpretation (INT) derived from CLSI 2023 M100 S33
Device manufacturers and users of FDA cleared devices shall consult the FDA’s Antibacterial Susceptibility Test Interpretive Criteria       website for breakpoints recognized or recommended by FDA, and for information regarding FDA exceptions or additions to the applicable, recognized consensus standard.
Molecular Mechanisms of Resistance
CategoryGene
No data available
 
Disclaimer:
Propagation
MEDIUM
Medium: Label

GROWTH CONDITIONS
Temperature: Label°C
Atmosphere: Label

PROPAGATION PROCEDURE
Label
Storage Temperature & Biosafety
STORAGE TEMPERATURE: °C

BIOSAFETY LEVEL:


Disclaimer:
Isolate History
Date Action Performed
04/10/23INT was updated with a new value for Amikacin: from 'S' to 'R'
10/12/22INT was updated with a new value for Imipenem/relebactam: from '---' to 'S'
10/12/22MIC was updated with a new value for Imipenem/relebactam: from '---' to '0.12'
10/12/22Drug was added: Imipenem/relebactam
Top of Page
TOP